Facilitating Access to Approved Medication
Get Access To Mitapivat Tablets

Mitapivat Tablets
- API: mitapivat
- Trade Name: On Request
- Packaging: tablets
- Strength: Tablets: 5 mg, 20 mg, and 50 mg.
- Indications:
What is Mitapivat Tablets used for?
Mitapivat is a medication used to treat hemolytic anemia. It is taken as the sulfate hydrate salt by mouth. Mitapivat is a pyruvate kinase activator.
Mitapivat was approved for medical use in the United States in February 2022 and in the European Union in November 2022.
Note: (For Prescribing Information Approved Drugs, see)
- The Food and Drug Administration (FDA), USA.
- The European Medicines Agency (EMA).
Disclaimer
All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Mitapivat Tablets is a pharmaceutical drug To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.